Larson Financial Group LLC Biotechnology

Larson Financial Group LLC

$2.44 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CORT Corcept Therapeutics Inc	$7.88B	$1,000 0.0% of portfolio	19	Q2 2025 Added 26.67%
APLS Apellis Pharmaceuticals, Inc.	$2.63B	$0 0.0% of portfolio	3	Q2 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$2.38B	$0 0.0% of portfolio	3	Q2 2025 New
HALO Halozyme Therapeutics, Inc.	$8.95B	$0 0.0% of portfolio	11	Q2 2025 Added 57.14%
RCUS Arcus Biosciences, Inc.	$698M	$0 0.0% of portfolio	17	Q2 2025 New
OCUL Ocular Therapeutix, Inc	$961M	$0 0.0% of portfolio	8	Q2 2025 New
KURA Kura Oncology, Inc.	$415M	$0 0.0% of portfolio	38	Q2 2025 Added 11.76%
IMNM Immunome Inc.	$120M	$0 0.0% of portfolio	67	Q2 2025 New
BEAM Beam Therapeutics Inc.	$1.19B	$0 0.0% of portfolio	44	Q2 2025 Added 46.67%
XBIT X Biotech Inc.	$90.4M	$0 0.0% of portfolio	21	Q2 2025 New
NTLA Intellia Therapeutics, Inc.	$825M	$0 0.0% of portfolio	69	Q2 2025 Added 130.0%
ACAD Acadia Pharmaceuticals Inc	$4.12B	$0 0.0% of portfolio	11	Q2 2025 New
BPMC Blueprint Medicines Corp	$7.73B	$0 0.0% of portfolio	3	Q2 2025 Added 50.0%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.88B	$0 0.0% of portfolio	9	Q2 2025 New
LGND Ligand Pharmaceuticals Inc	$2.58B	$0 0.0% of portfolio	2	Q2 2025 Added 100.0%
GLUE Monte Rosa Therapeutics, Inc.	$208M	$0 0.0% of portfolio	181	Q2 2025 Reduced 55.75%
AXSM Axsome Therapeutics, Inc.	$4.51B	$0 0.0% of portfolio	1	Q1 2025 New
ANVS Annovis Bio, Inc.	$22.6M	$0 0.0% of portfolio	300	Q2 2025 Added 100.0%
LXRX Lexicon Pharmaceuticals, Inc.	$200M	$0 0.0% of portfolio	100	Q2 2024 New
TYRA Tyra Biosciences, Inc.	$445M	$0 0.0% of portfolio	36	Q2 2025 New
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$0 0.0% of portfolio	3	Q2 2025 Reduced 25.0%
VERU Veru Inc.	$254M	$0 0.0% of portfolio	1,275	Q4 2022 New
VKTX Viking Therapeutics, Inc.	$3.06B	$0 0.0% of portfolio	16	Q2 2025 Reduced 15.79%
JANX Janux Therapeutics, Inc.	$1.01B	$0 0.0% of portfolio	6	Q1 2025 New
XNCR Xencor Inc	$463M	$0 0.0% of portfolio	8	Q2 2025 Added 60.0%
IDYA Ideaya Biosciences, Inc.	$1.13B	$0 0.0% of portfolio	14	Q2 2025 New
TECH Bio Techne Corp	$2.07B	$0 0.0% of portfolio	16	Q2 2025 Reduced 86.21%
EDIT Editas Medicine, Inc.	$157M	$0 0.0% of portfolio	244	Q2 2024 Reduced 67.2%
VXRT Vaxart, Inc.	$48.1M	$0 0.0% of portfolio	156	Q2 2021 Added 23.81%
ETNB 89bio, Inc.	$420M	$0 0.0% of portfolio	27	Q2 2025 New
STOK Stoke Therapeutics, Inc.	$533M	$0 0.0% of portfolio	22	Q2 2025 Reduced 42.11%
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	31	Q2 2025 New
CHRS Coherus Bio Sciences, Inc.	$71.5M	$0 0.0% of portfolio	79	Q2 2025 New
CDXC Chroma Dex Corp.	$420M	$0 0.0% of portfolio	37	Q2 2025 New
CGEM Cullinan Oncology, Inc.	$332M	$0 0.0% of portfolio	56	Q2 2025 Reduced 90.28%
OMER Omeros Corp	$262M	$0 0.0% of portfolio	150	Q2 2025 Reduced 40.0%
RCKT Rocket Pharmaceuticals, Inc.	$220M	$0 0.0% of portfolio	123	Q2 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	32	Q2 2025 New
VIR Vir Biotechnology, Inc.	$578M	$0 0.0% of portfolio	11	Q2 2025 Reduced 31.25%
KRYS Krystal Biotech, Inc.	$3.69B	$0 0.0% of portfolio	2	Q2 2025 New
IMCR Immunocore Holdings PLC	$1.4B	$0 0.0% of portfolio	10	Q4 2023 Reduced 23.08%
LQDA Liquidia Corp	$1.55B	$0 0.0% of portfolio	5	Q2 2025 Reduced 86.84%
ARCT Arcturus Therapeutics Holdings Inc.	$396M	$0 0.0% of portfolio	1	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.